Axsome Therapeutics, Inc. - Common Stock (AXSM)
CUSIP: 05464T104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 48,932,355
- Total 13F shares
- 40,712,369
- Share change
- +2,048,521
- Total reported value
- $3,277,256,100
- Put/Call ratio
- 123%
- Price per share
- $80.50
- Number of holders
- 253
- Value change
- +$165,407,783
- Number of buys
- 107
- Number of sells
- 127
Quarterly Holders Quick Answers
What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05464T104:
Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
9.2%
|
4,492,679
|
$358,515,784 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.6%
|
3,740,278
|
$298,474,185 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.5%
|
3,195,490
|
$255,000,103 | — | 31 Mar 2024 | |
| Fairmount Funds Management LLC |
13F
|
Company |
4.8%
|
2,360,077
|
$188,334,145 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
2.7%
|
1,304,721
|
$104,116,736 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.3%
|
1,143,644
|
$91,262,792 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.3%
|
1,105,341
|
$88,206,212 | — | 31 Mar 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2%
|
1,000,000
|
$79,800,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
943,883
|
$75,321,902 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.9%
|
938,716
|
$74,909,537 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
845,407
|
$67,473,975 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
1.7%
|
828,550
|
$66,118,315 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.5%
|
741,518
|
$59,173,136 | — | 31 Mar 2024 | |
| ALETHEA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
740,791
|
$59,115,122 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.4%
|
700,410
|
$55,893,000 | — | 31 Mar 2024 | |
| Bellevue Group AG |
13F
|
Company |
1.4%
|
685,476
|
$54,700,985 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.4%
|
676,646
|
$53,996,351 | — | 31 Mar 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.1%
|
520,750
|
$41,555,850 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.1%
|
515,000
|
$41,097,000 | — | 31 Mar 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.96%
|
467,427
|
$37,300,675 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.88%
|
431,000
|
$34,393,800 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
0.82%
|
400,000
|
$31,920,000 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.79%
|
385,551
|
$30,766,970 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.77%
|
378,864
|
$30,233,347 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.74%
|
360,128
|
$28,738,214 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.72%
|
352,366
|
$28,069,647 | — | 31 Mar 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
346,712
|
$27,667,618 | — | 31 Mar 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.7%
|
342,173
|
$27,305,405 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.69%
|
336,085
|
$26,819,583 | — | 31 Mar 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.68%
|
332,766
|
$26,554,727 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.62%
|
301,074
|
$24,025,705 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.6%
|
291,612
|
$23,270,638 | — | 31 Mar 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.57%
|
279,791
|
$22,327,000 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.5%
|
245,653
|
$19,603,109 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.5%
|
245,527
|
$19,593,054 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.45%
|
220,098
|
$17,563,819 | — | 31 Mar 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.46%
|
226,515
|
$17,439,389 | — | 31 Mar 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.43%
|
210,000
|
$16,758,000 | — | 31 Mar 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.42%
|
204,699
|
$16,334,980 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.41%
|
199,079
|
$15,886,504 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.4%
|
195,261
|
$15,581,828 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.38%
|
185,713
|
$14,819,896 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
153,771
|
$12,270,949 | — | 31 Mar 2024 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.29%
|
143,600
|
$11,459,280 | — | 31 Mar 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.29%
|
139,758
|
$11,152,688 | — | 31 Mar 2024 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.28%
|
138,300
|
$11,036,340 | — | 31 Mar 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.28%
|
138,000
|
$11,012,400 | — | 31 Mar 2024 | |
| US BANCORP \DE\ |
13F
|
Company |
0.27%
|
133,505
|
$10,653,699 | — | 31 Mar 2024 | |
| Checkpoint Capital L.P. |
13F
|
Company |
0.27%
|
132,437
|
$10,568,473 | — | 31 Mar 2024 | |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
|
Company |
0.26%
|
128,842
|
$10,281,592 | — | 31 Mar 2024 |
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q2 2024
As of 30 Jun 2024,
Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by
253 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,712,369 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, VANGUARD GROUP INC, BlackRock Inc., Fairmount Funds Management LLC, Deep Track Capital, LP, MACQUARIE GROUP LTD, RA CAPITAL MANAGEMENT, L.P., BVF INC/IL, EVENTIDE ASSET MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
254
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
254
Q2 2024 holders
253
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.